In this podcast, we talked with Dr. Alison Porter, Head of Expression System Sciences, Lonza, about the use of stable pool expression to reduce drug development timelines. Highlights included the implementation of stable pools in current workflows, expected titers, and cutting-edge applications of the technology.

Increasing speed and efficiency of biotherapeutic drug development with stable pools

The Cell Culture Dish (CCD) podcast covers areas important to the research, discovery, development, and manufacture of disease and biologic therapeutics. Key industry coverage areas include: drug discovery and development, stem cell research, cell and gene therapy, recombinant antibodies, vaccines, and emerging therapeutic modalities.

Share Increasing speed and efficiency of biotherapeutic drug development with stable pools

Sign up to save your podcasts

Increasing speed and efficiency of biotherapeutic drug development with stable pools

Increasing speed and efficiency of biotherapeutic drug development with stable pools